Corporate Finance

TCL launches its solar-powered 'Edelweiss Land' in Milan, a bold marketing move timed with the Winter Olympics that highlights its green ambitions.

Bitcoin Everlight's presale evokes Bitcoin's early days. We dive into whether this is a genuine revival of core ethos or a savvy marketing narrative.

Mawson Infrastructure reports a steep Q4 revenue drop but a smaller annual loss, clearing major legal hurdles to focus on its AI and green energy future.

A new partnership, featured on the Nasdaq Tower, combines AI e-commerce with specialized payment solutions to tackle the complexities of cross-border trade.

With a fresh $8.5M in funding and a powerful ally in KYMCO Capital, Sleek EV is accelerating its mission to dominate Southeast Asia's EV market.

A new cancer drug using DNA fragments to deliver chemotherapy more safely has been cleared for US trials, offering hope for less toxic treatments.

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

A historic $8 million donation, the largest in university history, will fund the new Rene’ Griffin Event Center, boosting athletics and regional growth.

Recognized as a Major Player by IDC, South Korea's SK shieldus leverages its AI platform to expand globally and serve businesses of all sizes.

Radisson Hotel Group signs a new RED hotel for Queenstown, signaling a strategic shift in the adventure capital's booming, high-value tourism market.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

Hawk Ridge Systems expands its portfolio with Stratasys' production-grade 3D printing, aiming to dominate the end-to-end additive manufacturing market.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

Viking Therapeutics' upcoming earnings call is about more than just financials. Investors are focused on key pipeline updates for its obesity and MASH drugs.

The homebuilder's 10% dividend hike reflects strong financials and hints at a broader recovery for the U.S. housing sector. What does this mean for investors?

GameAbove's new invitational isn't just another tournament; it's a strategic play to elevate women's golf, backed by millions in investment.

With the appointment of Kash Mohammed as President, intelliSPEC signals a major push to unify its platform and lead the AI revolution in industrial asset management.